Botox Cosmetic, botulinum toxin, has revolutionized the market of products to reduce wrinkles, particularly of the forehead. In April of 2002, the U.S. Food and Drug Administration approved Botox for the temporary improvement in the appearance of moderate to severe lines of the forehead in adult men and women. Botox derived from botulinum toxin has been used successfully for over 15 years for the treatment of various conditions.
Patients that benefit most from Botox are those who have wrinkles between their eyebrows who tend to appear tired, upset, or display a permanent scowl. Wrinkles between the eyebrows are caused by contracting muscles in the forehead, the corrugator and procerus muscles. A small amount of Botox is injected under the skin to paralyze the muscles in the face that pull the skin and cause wrinkles. The results we see at our Alpharetta botox clinic is a smoother, improved appearance between the eyebrows. The Botox we use at our Alpharetta botox clinic also can weaken the muscles in the forehead and around the eyes which means it's a great option for reducing the appearance of crows feet. The procedure at our Alpharetta botox clinic is minimally invasive, quick, and may have results that last up to four months.
Dr. Jeffrey Gallups and Dr. Mark Beaty are both double board certified in otolaryngology and facial plastic surgery in Georgia. They have personally treated thousands of patients at our Alpharetta botox clinic with Botox with great results. The cost of the Botox is individually determined by the Georgia plastic surgeon based on the patient's individual needs.
"Dr. Joseph, thank you for being so attentive to our little girl. She told all her friends that a Princess took out her tonsils, (she says you look like Princess Jasmine). From day one- We felt safe with you as her surgeon. As a parent, it was such a relief to know she was being cared for and felt a sense of security in your care."
- Georgette, Newnan, GA
In The News:
- Efficacy and safety of fluticasone furoate nasal spray in Japanese children with perennial allergic rhinitis: a multicentre, randomized, double-blind, placebo-controlled trial,0,15
- 7/31/2014 - Allergology International...
- Periostin and receptor activator of nuclear factor κ-B ligand expression in allergic fungal rhinosinusitis,0,15
- 7/31/2014 - International Forum of Allergy & Rhinology...
- Endoscopic staple diverticulostomy for Zenker’s diverticulum: review of experience in 337 cases,0,15
- 7/31/2014 - Annals of Otology, Rhinology & Laryngology...